covidscreen: a web app and R Package for assessing asymptomatic COVID-19 testing strategies

Author:

Smith Jesse,Sun Yilun,Hijano Diego R.,Hoffman James M.,Hakim Hana,Webby Richard J.,Hayden Randall T,Gaur Aditya H.,Armstrong Gregory T.,Mori Motomi,Tang LiORCID

Abstract

Abstract Background COVID-19 has caused over 305 million infections and nearly 5.5 million deaths globally. With complete eradication unlikely, organizations will need to evaluate their risk and the benefits of mitigation strategies, including the effects of regular asymptomatic testing. We developed a web application and R package that provides estimates and visualizations to aid the assessment of organizational infection risk and testing benefits to facilitate decision-making, which combines internal and community information with malleable assumptions. Results Our web application, covidscreen, presents estimated values of risk metrics in an intuitive graphical format. It shows the current expected number of active, primarily community-acquired infections among employees in an organization. It calculates and explains the absolute and relative risk reduction of an intervention, relative to the baseline scenario, and shows the value of testing vaccinated and unvaccinated employees. In addition, the web interface allows users to profile risk over a chosen range of input values. The performance and output are illustrated using simulations and a real-world example from the employee testing program of a pediatric oncology specialty hospital. Conclusions As the COVID-19 pandemic continues to evolve, covidscreen can assist organizations in making informed decisions about whether to incorporate covid test based screening as part of their on-campus risk-mitigation strategy. The web application, R package, and source code are freely available online (see “Availability of data and materials”).

Funder

American Lebanese Syrian Associated Charities

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health

Reference24 articles.

1. World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int. Accessed 10 Jan 2022.

2. The Economist. The pandemic’s true death toll. 2022. https://www.economist.com/graphic-detail/coronavirus-excess-deaths-estimates. Accessed 10 Jan 2022.

3. Ritchie H, Mathieu E, Rodés-Guirao L, Appel C, Giattino C, Ortiz-Ospina E, et al. Coronavirus Pandemic (COVID-19). Our World Data. 2020. https://ourworldindata.org/covid-vaccinations.

4. United Nations Development Programme. Global Dashboard for Vaccine Equity. UNDP Data Futures Platform. https://data.undp.org/vaccine-equity/. Accessed 10 Jan 2022.

5. Scientific Advisory Group for Emergencies. Long term evolution of SARS-CoV-2. 2021. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1007566/S1335_Long_term_evolution_of_SARS-CoV-2.pdf. Accessed 10 Jan 2022.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. FECNet: a Neural Network and a Mobile App for COVID-19 Recognition;Mobile Networks and Applications;2023-07-17

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3